BioCryst Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (22)

View All

Latest Posts

About This Stock More About This Stock
Premarket Biotech Digest – NOVN Reports Topline Results, INNV Receives New Patent, AIQ Signs Merger Agreement
Article By: KKD Healthcare Analytics
Wednesday, April 12, 2017 9:50 AM EST
Novan stock skyrocketed as the company reported positive topline results from the Company’s Phase 2 clinical trial with SB208. Alliance HealthCare Services announced signing a definitive merger agreement with Tahoe Investment Group.
In this article: AIQ, PLX, AVEO, BCRX, NBIX, MZOR, NOVN
Read
After Valeant, Here Are 5 Drug Stocks Bill Ackman Should Buy Instead
Article By: Arpita Dutt
Wednesday, March 15, 2017 12:57 PM EST
Here is a look at 5 drug stocks that could find a place in Ackman’s investment plans.
In this article: NEOS, CNCE, LOXO, NDRM, BCRX Also: VRX
Read
Unusual Options Activity: TSO, AMD, DAL & More
Article By: Mitchell Warren
Friday, December 30, 2016 9:28 AM EST
Here’s a weekly recap of 10 stocks that had unusual options activity and what, if any, significance these trades may have.
In this article: AMD, BCRX, CTSH, DAL, DKS, MDXG, NYCB, TSO, TV, WDC
Read
Biotechs Fade Again In Late Day Sell-Off
Article By: Rod Raynovich
Monday, December 19, 2016 8:51 PM EST
Biotech stocks got a jump-start this morning but peaked quickly then abruptly sold off at about 2p. The IBB ended down 1.33% to 268.79 off recent five-day highs of $274 and considerably off post-election highs of $293.
In this article: BMY, BCRX, IBB, CLVS, GILD, XBI, XLV, SUPN, TSRO
Read
E Biocryst Tumbles 71% After Phase 2 Trial Failure
Article By: Terry Chrisomalis
Tuesday, February 9, 2016 6:49 AM EST
Yesterday, shares of Biocryst Pharmaceuticals tumbled by 71% after the company announced that the phase 2 trial failed to produce statistically significant results.
In this article: BCRX
Read
All Posts

PARTNER HEADLINES

Latest Tweets for $BCRX

No tweets yet!

$BCRX

Comments Status Updates
After Valeant, Here Are 5 Drug Stocks Bill Ackman Should Buy Instead
Mitch Reynolds • 3/15/2017 6:34:03 PM

Great stock picks, thanks for the insight. $NEOS $CNCE $LOXO $NDRM $BCRX

1 to 1 of 1 comments